A Study of a Single Ascending Dose Study of DS-7011a in Healthy Subjects

NCT05203692 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Systemic Lupus Erythematosus

Interventions

DRUG: DS-7011a
DRUG: Placebo

Sponsor

Daiichi Sankyo